Celltrion
068270.KS
#767
Rank
โ‚น2.111 T
Marketcap
โ‚น9,701
Share price
-1.89%
Change (1 day)
-11.64%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Earnings for Celltrion (068270.KS)

Earnings in 2024 (TTM): โ‚น39.54 Billion

According to Celltrion 's latest financial reports the company's current earnings are โ‚น2.58 Billion. a decrease over its 2023 earnings that were of โ‚น44.12 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Celltrion from 2008 to 2024

Annual earnings

Year Earnings Change
2024 โ‚น40.24 B-8.8%
2023 โ‚น44.12 B6.8%
2022 โ‚น41.31 B-21.85%
2021 โ‚น52.86 B10.25%
2020 โ‚น47.95 B65.16%
2019 โ‚น29.03 B16.64%
2018 โ‚น24.88 B-33.89%
2017 โ‚น37.65 B106.53%
2016 โ‚น18.23 B25.57%
2015 โ‚น14.51 B-6.54%
2014 โ‚น15.53 B47.36%
2013 โ‚น10.54 B-33.63%
2012 โ‚น15.88 B
2010 โ‚น8.24 B72.84%
2009 โ‚น4.76 B260.54%
2008 โ‚น1.32 B